Article
Functional and structural insights into HCMV terminase accessory proteins pUL77 and pUL93.
Journal of virology - 23 Oct 2025
Gourin C, Di Meo F, Delmon C, Alain S, Hantz S
Abstract excerpt
Human cytomegalovirus (HCMV) is a significant cause of morbidity and mortality in immunocompromised and congenitally infected patients. Current antiviral therapies, primarily targeting the viral DNA polymerase, are limited by toxicity and resistance, underscoring the need for novel therapeutic strategies. Letermovir (LTV), which targets the viral terminase complex (pUL56-pUL89-pUL51), has improved prophylaxis in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
